An agonist of REV-ERB—a core driver of circadian mechanism—reduced the expression and activation of NLRP3 following ischemia/reperfusion of mouse heart and thereby prevents the development of HF (Reitz et al., 2019). Here, NLRP3 is linked to hydrops fetalis.